MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

PURPOSE: Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer. METHODS: miR-100...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrelli, Annalisa, Bellomo, Sara Erika, Sarotto, Ivana, Kubatzki, Franziska, Sgandurra, Paola, Maggiorotto, Furio, Di Virgilio, Maria Rosaria, Ponzone, Riccardo, Geuna, Elena, Galizia, Danilo, Nuzzo, Anna Maria, Medico, Enzo, Miglio, Umberto, Berrino, Enrico, Venesio, Tiziana, Ribisi, Salvatore, Provero, Paolo, Sapino, Anna, Giordano, Silvia, Montemurro, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597498/
https://www.ncbi.nlm.nih.gov/pubmed/33122354
http://dx.doi.org/10.1136/esmoopen-2020-000937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597498/
https://www.ncbi.nlm.nih.gov/pubmed/33122354
http://dx.doi.org/10.1136/esmoopen-2020-000937

Ejemplares similares